BioTissue (Biotechnology) Overview
- Year Founded
-
2001
- Status
-
Private
- Employees
-
384
- Latest Deal Type
-
2ndary - Private
- Investors
-
3
BioTissue (Biotechnology) General Information
Description
Developer of a medical technology platform designed to solve unmet clinical needs of birth-tissue regenerative medicine. The company's platform uses a tissue-processing method that preserves the innate biological and structural integrity of the natural placental tissue and delivers the anti-inflammatory, anti-scarring, and anti-angiogenesis properties of that matrix, enabling healthcare professionals to deliver optimal patient healing outcomes.
Contact Information
Website
www.biotissue.comCorporate Office
- 7300 Corporate Center Drive
- Suite 700
- Miami, FL 33126
- United States
Corporate Office
- 7300 Corporate Center Drive
- Suite 700
- Miami, FL 33126
- United States
BioTissue (Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 20. Secondary Transaction - Private | 27-Feb-2026 | Completed | Profitable | |||
| 19. Later Stage VC | 01-Mar-2024 | Completed | Profitable | |||
| 18. Debt - General | 01-Apr-2022 | Completed | Profitable | |||
| 17. Later Stage VC | 24-May-2021 | Completed | Profitable | |||
| 16. Debt - PPP | 13-Apr-2020 | Completed | Profitable | |||
| 15. Secondary Transaction - Private | 30-Sep-2019 | Completed | Profitable | |||
| 14. Later Stage VC (Series C) | 26-Jun-2019 | Completed | Profitable | |||
| 13. Debt - General | 09-Nov-2016 | Completed | Profitable | |||
| 12. Grant | 01-Jan-2016 | $1M | $45M | Completed | Profitable | |
| 11. Later Stage VC (Series B) | 15-Jun-2015 | $25M | $45M | Completed | Profitable |
BioTissue (Biotechnology) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 4,000,000 | $0.001000 | 5% | $6.9 | $6.9 | 1x | $6.9 | 17.26% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
BioTissue (Biotechnology) Comparisons
Industry
Financing
Details
BioTissue (Biotechnology) Competitors (15)
One of BioTissue (Biotechnology)’s 15 competitors is Episkin, a Corporation company based in Lyon, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Episkin | Corporation | Lyon, France | ||||
| Emulate | Venture Capital-Backed | Boston, MA | ||||
| MatTek | Corporate Backed or Acquired | Ashland, MA | ||||
| Augurex | Venture Capital-Backed | Vancouver, Canada | ||||
| InSphero | Private Equity-Backed | Schlieren, Switzerland |
BioTissue (Biotechnology) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
BioTissue (Biotechnology) Patents
BioTissue (Biotechnology) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260041718-A1 | Compositions, devices, and methods relating to use of an amniotic membrane fetal tissue product | Pending | 03-Jun-2024 | ||
| WO-2025255011-A1 | Compositions, devices, and methods relating to use of an amniotic membrane fetal tissue product | Pending | 03-Jun-2024 | ||
| AU-2023259072-A1 | Compositions and methods relating to pooled fetal support tissue | Pending | 25-Apr-2022 | ||
| EP-4514366-A1 | Compositions and methods relating to pooled fetal support tissue | Pending | 25-Apr-2022 | ||
| EP-4514366-A4 | Compositions and methods relating to pooled fetal support tissue | Pending | 25-Apr-2022 | A61K35/50 |
BioTissue (Biotechnology) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
BioTissue (Biotechnology) Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Revelation Partners | Venture Capital | Minority | ||
| EW Healthcare Partners | Growth/Expansion | Minority | ||
| Ballast Point Partners | Growth/Expansion | Minority |
BioTissue (Biotechnology) FAQs
-
When was BioTissue (Biotechnology) founded?
BioTissue (Biotechnology) was founded in 2001.
-
Where is BioTissue (Biotechnology) headquartered?
BioTissue (Biotechnology) is headquartered in Miami, FL.
-
What is the size of BioTissue (Biotechnology)?
BioTissue (Biotechnology) has 384 total employees.
-
What industry is BioTissue (Biotechnology) in?
BioTissue (Biotechnology)’s primary industry is Biotechnology.
-
Is BioTissue (Biotechnology) a private or public company?
BioTissue (Biotechnology) is a Private company.
-
What is BioTissue (Biotechnology)’s current revenue?
The current revenue for BioTissue (Biotechnology) is .
-
How much funding has BioTissue (Biotechnology) raised over time?
BioTissue (Biotechnology) has raised $221M.
-
Who are BioTissue (Biotechnology)’s investors?
Revelation Partners, EW Healthcare Partners, and Ballast Point Partners have invested in BioTissue (Biotechnology).
-
Who are BioTissue (Biotechnology)’s competitors?
Episkin, Emulate, MatTek, Augurex, and InSphero are some of the 15 competitors of BioTissue (Biotechnology).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
